Schedule 13G ownership disclosure
BIOLINE RX LIMITED
Ordinary Shares, par value NIS 0.10 per share · CUSIP: 09071M304
Event date: 2025-06-30
- Filing-level shares
- 172,950,600.00
- Percent of class
- 7.2%
- Highbridge Capital Management, LLC
Shares: 172,950,600.00 · Class: 7.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-25-003619
- Form type
- SCHEDULE 13G
- Filer
- BioLineRx Ltd.
- CIK
- CIK 1498403
- Filed
- Aug 14, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership